Overview

Acute kidney injury treatment market is expected to value over USD 1.8 billion by 2027 end and register a CAGR of over 6.4% during the forecast period 2020-2027.

Increasing technological advancements, rising geriatric population, and increasing patient population remain the major factors stimulating the market growth. Technological advancements coupled with rising research and development activities are expected to expand the market size.

Favorable initiatives launched by governments is expected to be the new acute kidney treatment injury treatment market trend.

The market is bifurcated on the basis of type, end-user, and region. In terms of type, prerenal acute kidney injury is expected to hold a major market share. Rise in the geriatric population and increasing cases of heart failure have contributed towards the market growth. Additionally, low blood pressure and liver cirrhosis are also factors burgeoning market growth.

In terms of end-user, hospitals control the growth of the market. The rapid expansion of hospitals in developed economies alongside favorable government initiatives is fueling the market growth as well.

Based on regions, market size is expected to multiply in the North America region. The availability of efficient and developed healthcare infrastructure remains the key factor in escalating the market growth in the region. Increasing government approval is also spiking the market in the region. Rapidly increasing clinical pipeline and growing patient population are propelling the market proliferation in the growth.

Asia-Pacific is also projected to be a lucrative region owing to the large penetration of prominent players and rapidly expanding the healthcare sector in the region. Increasing geriatric population in countries like Japan and China is expected to drive the market growth. Growing urbanization and rising critical care admissions are expected to positively influence the market.

Prominent players of the market are AM-Pharma, Fresenius Medical Care AG & Co. KgaA., LG Chem., Asahi Kasei Medical, Angion Biomedia Corp., Baxter International, Inc., B.Braun Melsungen AG and Quark Pharmaceuticals, Inc.

Acute Kidney Injury Treatment market

Acute Kidney Injury Treatment Market Segmentation:

By Type

Prerenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury
Postrenal Acute Kidney Injury

By Treatment

Hemodialysis
Continuous Renal Replacement Therapy
Sustained low-efficiency dialysis
Others

By End-User

Hospitals
Ambulatory Surgical Centers
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

FutureWise Key Takeaways:

Dialysis sector is expected to create a vast impact on the market as it's essential for critically ill patients
Expansion of dialysis centers worldwide is expected to drive the market
The governments of developing economies are setting up new dialysis centers, thus propelling the market growth
Abu Dhabi Services Company and Abu Dhabi General Services Company announced to establish a state-of-the-art dialysis center in UAE. The centre would contain units of 65 kidney dialysis. As a result, increasing in number of dialysis centers offers immense opportunities for market growth

Objectives of the Study:

To provide with an exhaustive analysis on market by end-user, by type and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies